← Back to Search

Behavioral Intervention

Gamification for Improving Mobility After Hospitalization (MOVE_ON Trial)

N/A

Waitlist Available

Led By Ryan Greysen, MD, MHS, MA

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 26 and 52 weeks- end of the study (weeks 1-52)

Awards & highlights

MOVE_ON Trial Summary

This trial aims to use games & social rewards to help older adults stay active & reduce risk of mobility disability after hospital discharge.

Who is the study for?

This trial is for adults aged 50 or older who can walk on their own and were recently in the hospital for conditions like heart failure, high blood pressure, diabetes, or mobility issues. They must be able to use a smartphone with a wearable device daily and not be part of another physical activity study.Check my eligibility

What is being tested?

The study tests if adding game-like elements with social rewards can help older adults stay active after leaving the hospital. The goal is to see if this approach prevents them from losing their ability to move around easily.See study design

What are the potential side effects?

Since this trial involves non-medical interventions like gamification and social support rather than drugs, traditional side effects are not expected. However, participants may experience fatigue or discomfort from increased physical activity.

MOVE_ON Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 26 and 52 weeks- end of the study (weeks 1-52)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 26 and 52 weeks- end of the study (weeks 1-52)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 26 and 52 weeks- end of the study (weeks 1-52) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in mean daily step count from baseline to the end of the 26 week intervention period.

Secondary outcome measures

Change in mean daily step count from baseline to the end of the 26 week follow-up period.

Participants' acute care utilization throughout the entire study (Baseline to end of study [52 weeks]).

Participants' mobility disability throughout the entire study (Baseline to end of study [52 weeks]).

MOVE_ON Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Social Support GamificationExperimental Treatment1 Intervention

Intervention participants will receive a wearable device (e.g. FitBit) and will enter a game designed with behavioral economics concepts to address predictable barriers to behavior change during a 26-week intervention period. Participants will also work with a virtual health coach throughout the intervention period to increase their physical activity. At the end of the 26 week intervention period, participants will enter a 26 week follow-up period during which interventions will cease but passive data collection of step counts will continue. Participants will also complete milestones within the study, such as the Function assessment during the 6, and 12-month timepoints in the study. They will also complete a series of surveys during the 3, 6, 9, and 12-month timepoints in the study. Participants will complete an end-of-study questionnaire on their experience with the wearable device and time in the study.

Group II: ControlActive Control1 Intervention

Participants will receive a wearable device (e.g. FitBit) but no other interventions during the intervention or follow-up periods.Participants will complete milestones within the study, such as the Function assessment during the 6, and 12-month timepoints in the study. They will also complete a series of surveys during the 3, 6, 9, and 12-month timepoints in the study. Participants will complete an end-of-study questionnaire on their experience with the wearable device and time in the study.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,000 Previous Clinical Trials

42,879,788 Total Patients Enrolled

42 Trials studying Heart Failure

7,214 Patients Enrolled for Heart Failure

National Institute on Aging (NIA)NIH

1,668 Previous Clinical Trials

28,004,764 Total Patients Enrolled

42 Trials studying Heart Failure

213,015 Patients Enrolled for Heart Failure

Ryan Greysen, MD, MHS, MAPrincipal InvestigatorUniversity of Pennsylvania

4 Previous Clinical Trials

657 Total Patients Enrolled

2 Trials studying Heart Failure

383 Patients Enrolled for Heart Failure

Media Library

Social Support Gamification (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05736484 — N/A

Heart Failure Research Study Groups: Social Support Gamification, Control

Heart Failure Clinical Trial 2023: Social Support Gamification Highlights & Side Effects. Trial Name: NCT05736484 — N/A

Social Support Gamification (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05736484 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any new participants being recruited for the research program at this time?

"Currently, this particular medical trial has halted the recruitment of patients. The original post was on July 1st 2023 and it was recently edited February 17th 2023. Although this specific study is no longer recruiting, there are a plethora of other trials with open enrolment at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Randomized Clinical Trial to Improve Mobility After Hospitalization

2023. "Randomized Clinical Trial to Improve Mobility After Hospitalization". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05736484.